Yibing Bai
Overview
Explore the profile of Yibing Bai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang M, Zhou X, Feng Y, Ding P, Li J, Lu D, et al.
Int J Biol Sci
. 2025 Feb;
21(4):1585-1602.
PMID: 39990668
Changes in DNA methylation patterns, in which DNA methyltransferases such as DNA methyltransferase 3 alpha (DNMT3a) play important roles, are closely related to the occurrence and development of tumours. However,...
2.
Zhang F, Li T, Bai Y, Liu J, Qin J, Wang A, et al.
J Transl Int Med
. 2024 Jul;
12(3):317-320.
PMID: 39081279
No abstract available.
3.
Bai Y, Wang Y, Qin J, Wang T, Zhou X, Ma Z, et al.
Heliyon
. 2024 Jul;
10(12):e33304.
PMID: 39022053
Background: Ras association domain family member 1 (RASSF1) encodes the RASSF1A protein, serving as a scaffold protein situated at the intersection of a complex signalling network. Aims: To evaluate the...
4.
Bai Y, Yang W, Kasmann L, Sorich M, Tao H, Hu Y
Transl Lung Cancer Res
. 2024 Mar;
13(2):398-422.
PMID: 38496691
Background And Objective: Lung cancer, mainly non-small cell lung cancer (NSCLC), is a serious threat to human life. In particular, the prognosis for advanced patients is poor, with the 5-year...
5.
Bai Y, Li T, Wang Q, You W, Yang H, Xu X, et al.
EMBO Mol Med
. 2024 Jan;
16(2):334-360.
PMID: 38177537
Cancer immunotherapies have achieved unprecedented success in clinic, but they remain largely ineffective in some major types of cancer, such as colorectal cancer with microsatellite stability (MSS CRC). It is...
6.
Long Y, Yang W, Bai Y, Tao H, Zhang F, Wang L, et al.
Cancer Cell Int
. 2023 Sep;
23(1):224.
PMID: 37777758
Background: Hyper progressive disease (HPD) describes the phenomenon that patients can't benefit from immunotherapy but cause rapid tumor progression. HPD is a particular phenomenon in immunotherapy but lacks prediction methods....
7.
Bai Y, Zhao B, Ni J, Sun L, Wang Y, Wang J, et al.
RSC Adv
. 2023 Aug;
13(34):23728-23735.
PMID: 37555088
Carbon nanodots (CNDs) which demonstrate concentration-dependent emission and have a photoluminescence quantum yield of 45% were designed. Transparent CND-containing composite films (CND-films), obtained by combining the CNDs with polyvinyl alcohol...
8.
Yan C, Zheng L, Jiang S, Yang H, Guo J, Jiang L, et al.
Cancer Cell
. 2023 May;
41(7):1276-1293.e11.
PMID: 37244259
The concept of targeting cholesterol metabolism to treat cancer has been widely tested in clinics, but the benefits are modest, calling for a complete understanding of cholesterol metabolism in intratumoral...
9.
Yang W, Li T, Bai Y, Long Y, Gao M, Wang T, et al.
Front Oncol
. 2023 May;
13:1147903.
PMID: 37124534
Importance: Both pembrolizumab and sintilimab have been approved by the Chinese State Drug Administration (NMPA) for the first-line treatment of patients with advanced squamous lung cancer. The differences of the...
10.
Han Y, Huang X, Liu J, Ni J, Bai Y, Zhao B, et al.
J Colloid Interface Sci
. 2022 Mar;
617:44-52.
PMID: 35259510
The intensity of blue light in white light emitting diodes is typically higher than that of the green and red-light components in screen displays and lighting systems. To reduce the...